BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 25395423)

  • 21. Asp1424Asn MYH9 mutation results in an unstable protein responsible for the phenotypes in May-Hegglin anomaly/Fechtner syndrome.
    Deutsch S; Rideau A; Bochaton-Piallat ML; Merla G; Geinoz A; Gabbiani G; Schwede T; Matthes T; Antonarakis SE; Beris P
    Blood; 2003 Jul; 102(2):529-34. PubMed ID: 12649151
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential expression of wild-type and mutant NMMHC-IIA polypeptides in blood cells suggests cell-specific regulation mechanisms in MYH9 disorders.
    Kunishima S; Hamaguchi M; Saito H
    Blood; 2008 Mar; 111(6):3015-23. PubMed ID: 18192507
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Defective expression of GPIb/IX/V complex in platelets from patients with May-Hegglin anomaly and Sebastian syndrome.
    Di Pumpo M; Noris P; Pecci A; Savoia A; Seri M; Ceresa IF; Balduini CL
    Haematologica; 2002 Sep; 87(9):943-7. PubMed ID: 12217806
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulation of platelet biogenesis: insights from the May-Hegglin anomaly and other MYH9-related disorders.
    Chen Z; Shivdasani RA
    J Thromb Haemost; 2009 Jul; 7 Suppl 1():272-6. PubMed ID: 19630815
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical, pathological, and genetic analysis of ten patients with MYH9-related disease.
    Sun XH; Wang ZY; Yang HY; Cao LJ; Su J; Yu ZQ; Bai X; Ruan CG
    Acta Haematol; 2013; 129(2):106-13. PubMed ID: 23207509
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Haematological characteristics of MYH9 disorders due to MYH9 R702 mutations.
    Kunishima S; Yoshinari M; Nishio H; Ida K; Miura T; Matsushita T; Hamaguchi M; Saito H
    Eur J Haematol; 2007 Mar; 78(3):220-6. PubMed ID: 17241369
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Heavy chain myosin 9-related disease (MYH9 -RD): neutrophil inclusions of myosin-9 as a pathognomonic sign of the disorder.
    Savoia A; De Rocco D; Panza E; Bozzi V; Scandellari R; Loffredo G; Mumford A; Heller PG; Noris P; De Groot MR; Giani M; Freddi P; Scognamiglio F; Riondino S; Pujol-Moix N; Fabris F; Seri M; Balduini CL; Pecci A
    Thromb Haemost; 2010 Apr; 103(4):826-32. PubMed ID: 20174760
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Autosomal dominant macrothrombocytopenia with leukocyte inclusion bodies and MYH9 disorders].
    Kunishima S
    Rinsho Byori; 2009 Apr; 57(4):365-70. PubMed ID: 19489439
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nonmuscle myosin heavy chain IIA mutations define a spectrum of autosomal dominant macrothrombocytopenias: May-Hegglin anomaly and Fechtner, Sebastian, Epstein, and Alport-like syndromes.
    Heath KE; Campos-Barros A; Toren A; Rozenfeld-Granot G; Carlsson LE; Savige J; Denison JC; Gregory MC; White JG; Barker DF; Greinacher A; Epstein CJ; Glucksman MJ; Martignetti JA
    Am J Hum Genet; 2001 Nov; 69(5):1033-45. PubMed ID: 11590545
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recent advances in the understanding and management of MYH9-related inherited thrombocytopenias.
    Balduini CL; Pecci A; Savoia A
    Br J Haematol; 2011 Jul; 154(2):161-74. PubMed ID: 21542825
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MYH9: Structure, functions and role of non-muscle myosin IIA in human disease.
    Pecci A; Ma X; Savoia A; Adelstein RS
    Gene; 2018 Jul; 664():152-167. PubMed ID: 29679756
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nonmuscle Myosin Heavy Chain IIA Mutation Predicts Severity and Progression of Sensorineural Hearing Loss in Patients With MYH9-Related Disease.
    Verver EJ; Topsakal V; Kunst HP; Huygen PL; Heller PG; Pujol-Moix N; Savoia A; Benazzo M; Fierro T; Grolman W; Gresele P; Pecci A
    Ear Hear; 2016; 37(1):112-20. PubMed ID: 26226608
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mice lacking the ITIM-containing receptor G6b-B exhibit macrothrombocytopenia and aberrant platelet function.
    Mazharian A; Wang YJ; Mori J; Bem D; Finney B; Heising S; Gissen P; White JG; Berndt MC; Gardiner EE; Nieswandt B; Douglas MR; Campbell RD; Watson SP; Senis YA
    Sci Signal; 2012 Oct; 5(248):ra78. PubMed ID: 23112346
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MYH9-macrothrombocytopenia caused by a novel variant (E1421K) initially presenting as apparent neonatal alloimmune thrombocytopenia.
    Samelson-Jones BJ; Kramer PM; Chicka M; Gunning WT; Lambert MP
    Pediatr Blood Cancer; 2018 Apr; 65(4):. PubMed ID: 29286575
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The May-Hegglin anomaly gene MYH9 is a negative regulator of platelet biogenesis modulated by the Rho-ROCK pathway.
    Chen Z; Naveiras O; Balduini A; Mammoto A; Conti MA; Adelstein RS; Ingber D; Daley GQ; Shivdasani RA
    Blood; 2007 Jul; 110(1):171-9. PubMed ID: 17392504
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of the first in cis mutations in MYH9 disorder.
    Miyajima Y; Kunishima S
    Eur J Haematol; 2009 Apr; 82(4):288-91. PubMed ID: 19191864
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Accumulation of MYH9 mRNA at leukocyte inclusion bodies in MYH9 disorders.
    Kunishima S; Hirano K; Hamaguchi M; Saito H
    Eur J Haematol; 2008 Oct; 81(4):325-6. PubMed ID: 18616507
    [No Abstract]   [Full Text] [Related]  

  • 38. MYH9-Related Thrombocytopenia: Four Novel Variants Affecting the Tail Domain of the Non-Muscle Myosin Heavy Chain IIA Associated with a Mild Clinical Evolution of the Disorder.
    Zaninetti C; De Rocco D; Giangregorio T; Bozzi V; Demeter J; Leoni P; Noris P; Ryhänen S; Barozzi S; Pecci A; Savoia A
    Hamostaseologie; 2019 Feb; 39(1):87-94. PubMed ID: 29996171
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunofluorescence analysis of neutrophil nonmuscle myosin heavy chain-A in MYH9 disorders: association of subcellular localization with MYH9 mutations.
    Kunishima S; Matsushita T; Kojima T; Sako M; Kimura F; Jo EK; Inoue C; Kamiya T; Saito H
    Lab Invest; 2003 Jan; 83(1):115-22. PubMed ID: 12533692
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epstein syndrome: another renal disorder with mutations in the nonmuscle myosin heavy chain 9 gene.
    Seri M; Savino M; Bordo D; Cusano R; Rocca B; Meloni I; Di Bari F; Koivisto PA; Bolognesi M; Ghiggeri GM; Landolfi R; Balduini CL; Zelante L; Ravazzolo R; Renieri A; Savoia A
    Hum Genet; 2002 Feb; 110(2):182-6. PubMed ID: 11935325
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.